Angiogenesis and the regulation of the antitumour defence;Angiogenese en de regulatie van de afweer tegen tumoren

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 30, 1999, Pages 1555-1559

  Pappas, N P ^a   Hillen, H F P ^a   Wagstaff, J ^a   Griffioen, A W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; CD34 ANTIGEN; ENDOSTATIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; THROMBOCYTE FACTOR 4; THROMBOSPONDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; HUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; TUMOR VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANTINEOPLASTIC AGENTS; CELL ADHESION MOLECULES; HUMANS; LEUKOCYTES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0033600476     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Verheul HMW, Bom JBM, Hoekman K, Pinedo HM. Remming van tumorangiogenese als behandeling van kanker. Ned Tijdschr Geneeskd 1999;143:1549-55.
2. Molema G, Ciriffioen AW. Rocking the foundations of solid tumor growth by attacking the tumor's blood supply. Immunol Today 1998; 19:392-4.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
4. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Alfred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997;150: 815-21.
5. Foss HD, Araujo I, Demel G, Klotzbach H, Hummel M, Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 1997;183:44-50.
6. Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997;89: 1870-5.
7. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995;55: 4140-5.
8. Griffioen AW. Phenotype of the tumor vasculature: cell adhesion as a target for tumor therapy. Cancer J 1997;10:249-55.
9. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res 1996;56:1111-7.
10. Kitayama J, Nagawa H, Yasuhara H, Tsuno N, Kimura W, Shibata Y, et al. Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(+) T-lymphocyte. Cancer Res 1994; 54:4729-33.
11. Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 1996;88:667-73.
12. Griffioen AW, Relou IAM, Gallardo Torres HI, Damen CA, Graaf JC de, Zwaginga JJ, et al. Tumor angiogenesis impairs leukocyte adhesion and rolling under flow conditions. Angiogenesis 1999;2: 45-50.
13. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 1996;2:992-7.
14. Griffioen AW, Coenen MJH, Damen CA, Hellwig SMM, Weering DHJ van, Vooys W, et al. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood 1997;90: 1150-9.
15. Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, Rifkin DB. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell 1993;4:973-82.
16. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994;264:569-71.
17. Griffioen AW, Tromp SC, Hillen HFP. Angiogenesis modulates the tumor immune response. Int J Exp Pathol 1998;79:363-8.
18. Griffioen AW, Damen CA, Mayo K, Barendsz-Janson AF, Martinotti S, Blijham GH, et al. Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int J Cancer 1999;80:315-9.
19. Rasmussen HS, McCann PP. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 1997;75:69-75.
20. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79:315-28.
21. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
22. Mayo KH, Ilyina E, Park H. A recipe for designing water-soluble, beta-sheet-forming peptides. Protein Sci 1996;5:1301-15.